Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
Applied DNA Sciences (APDN) reported a Q4 loss of $0.32 per share, which was better than the Zacks Consensus Estimate of a $0.33 loss. This is an improvement from the $5.20 loss per share a year ago.
December 17, 2024 | 11:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Applied DNA Sciences reported a Q4 loss of $0.32 per share, better than the expected $0.33 loss, and a significant improvement from last year's $5.20 loss per share.
The better-than-expected earnings report and significant improvement from the previous year's loss are likely to positively impact APDN's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100